WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006082072) USE OF ACTIVE INGREDIENTS CONTAINING HYDROXYSTILBENE FOR PREVENTING AND/OR TREATING OSTEOPOROSIS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/082072    International Application No.:    PCT/EP2006/000956
Publication Date: 10.08.2006 International Filing Date: 03.02.2006
Chapter 2 Demand Filed:    17.11.2006    
IPC:
A61K 31/085 (2006.01), A61K 31/7034 (2006.01), A61K 36/708 (2006.01), A61P 19/10 (2006.01)
Applicants: HEGER, Peter [DE/DE]; (DE).
RETTENBERGER, Reinhard [DE/DE]; (DE).
SPAICH, Carl-Friedrich [DE/DE]; (DE)
Inventors: HEGER, Peter; (DE).
RETTENBERGER, Reinhard; (DE).
SPAICH, Carl-Friedrich; (DE)
Agent: SCHWEIGER, Georg; Reitstötter, Kinzebach & Partner (GbR), Sternwartstrasse 4, 81679 München (DE)
Priority Data:
10 2005 005 268.1 04.02.2005 DE
10 2005 005 271.1 04.02.2005 DE
10 2005 005 277.0 04.02.2005 DE
Title (DE) VERWENDUNG VON HYDROXYSTILBEN-HALTIGEN WIRKSTOFFEN ZUR PRÄVENTION UND/ODER BEHANDLUNG VON OSTEOPOROSE
(EN) USE OF ACTIVE INGREDIENTS CONTAINING HYDROXYSTILBENE FOR PREVENTING AND/OR TREATING OSTEOPOROSIS
(FR) UTILISATION DE PRINCIPES ACTIFS CONTENANT DE L'HYDROXYSTILBENE POUR LA PREVENTION ET/OU LE TRAITEMENT DE L'OSTEOPOROSE
Abstract: front page image
(DE)Die Erfindung betrifft die Verwendung einer Kombination Hydroxystilben-haltigen Wirkstoffe, ausgewählt unter Resveratrol- und Piceatannol-Vorläufem und funktionellen Derivaten davon; sowie deren stereoisomeren Formen, jeweils in Form ihrer Salze oder in der Phenolform, zur Herstellung eines Mittels zur Prävention und/oder Behandlung von Osteoporose.
(EN)The invention relates to the use of a combination of active ingredients containing hydroxystilbene, selected from resveratrol and piceatannol precursors and functional derivatives thereof, in addition to the use of the stereoisomeric forms of said ingredients, in the form of salts or phenol respectively, for producing an agent for the prevention and/or treatment of osteoporosis.
(FR)L'invention concerne l'utilisation d'une combinaison de principes actifs contenant de l'hydroxystilbène, sélectionnés parmi des précurseurs du resvératrol et du picéatannol et leurs dérivés fonctionnels, ainsi que leurs formes stéréo-isomères, respectivement sous leurs formes de sels ou sous la forme phénol, pour produire un agent servant à prévenir et/ou à traiter l'ostéoporose.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)